Weight-loss injections — commonly called “fat jabs” — have transformed obesity treatment in the UK. Whether you’re considering the NHS route or exploring private options, understanding the eligibility criteria in 2026 is essential before booking any appointment or spending money on treatment.
What Are Fat Jabs?
Fat jabs refer primarily to GLP-1 receptor agonist medications, including semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro). These injectable medicines work by mimicking gut hormones that regulate appetite and blood sugar, helping patients feel fuller for longer and consume fewer calories overall. They are prescription-only medicines in the UK and cannot legally be dispensed without a clinical assessment.
Sarah’s perspective: As a certified personal trainer with 8 years of UK experience, I only recommend what I’ve seen work consistently with real clients. Everything on this page comes from direct professional experience — not theory or marketing copy.
“Over the past two years, I’ve worked alongside GP surgeries and specialist weight management clinics supporting clients using GLP-1 medications. The most common mistake I see is people assuming they automatically qualify because their BMI is above 30. The full clinical picture — including metabolic health markers and previous interventions — matters enormously. Getting a proper assessment protects both your health and your wallet.”
NHS Eligibility Criteria 2026
NHS access to weight-loss injections is governed by NICE technology appraisal guidance TA875 for semaglutide (Wegovy) and separate guidance for tirzepatide. To qualify through the NHS, you generally must meet all of the following conditions:
- BMI of 35 or above (or 30+ with at least one weight-related health condition such as type 2 diabetes, hypertension, or sleep apnoea)
- Referred to, and actively engaged with, a specialist NHS Tier 3 weight management service
- Evidence of having tried lifestyle interventions (diet and exercise programmes) without sufficient long-term success
- No contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
- Not currently pregnant or breastfeeding
It is also worth noting that NHS prescribing capacity remains limited. The NHS treatment page for obesity confirms that rollout is being phased, meaning waiting times for Tier 3 services can stretch to 18 months or longer in some regions.
Private Eligibility Criteria 2026
Private providers — including online clinics and high-street pharmacies — typically apply more accessible but still clinically valid criteria. A legitimate private prescriber will require a consultation, medical history review, and in many cases baseline blood tests before issuing a prescription.
